Maternal oncostatin M levels in gestational diabetes mellitus: associations with metabolic dysfunction and pregnancy outcomes.
文献摘要
Objective Gestational diabetes mellitus is characterized by metabolic dysfunction and altered inflammatory signaling. The aim of this study was to evaluate maternal serum oncostatin M levels in pregnancies complicated by gestational diabetes mellitus and explore their associations with metabolic and pregnancy outcomes. Methods In this prospective case-control study, 40 women with gestational diabetes mellitus and 40 healthy pregnant controls were enrolled. Maternal serum oncostatin M concentrations were measured during the third trimester using an enzyme-linked immunosorbent assay. Results Maternal serum oncostatin M levels were significantly lower in women with gestational diabetes mellitus than in controls (28.7 vs. 64.0 ng/L, p=0.001). Oncostatin M levels were negatively correlated with body mass index, insulin, hemoglobin A1c, and Homeostatic Model Assessment of Insulin Resistance, and positively correlated with gestational age at delivery (all p Conclusion Maternal oncostatin M levels are reduced in gestational diabetes mellitus and are associated with markers of metabolic dysfunction, supporting a potential association with the immunometabolic adaptations of diabetic pregnancy.